A novel peptide interferes with Mycobacterium tuberculosis virulence and survival

被引:2
|
作者
Samuchiwal, Sachin Kumar [1 ]
Tousif, Sultan [2 ,3 ,5 ]
Singh, Dhiraj Kumar [2 ]
Kumar, Arun [2 ]
Ghosh, Anamika [1 ]
Bhalla, Kuhulika [1 ]
Prakash, Prem [1 ]
Kumar, Sushil [1 ]
Trivedi, Ashish Chandra [4 ]
Bhattacharyya, Maitree [3 ]
Das, Gobardhan [5 ]
Ranganathan, Anand [1 ]
机构
[1] ICGEB, Recombinant Gene Prod Grp, Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India
[2] ICGEB, Immunol Grp, Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India
[3] Univ Calcutta, Dept Biochem, Kolkata 700019, India
[4] IMT Manesar, Innovat Life Discoveries Pvt Ltd, Manesar, Haryana, India
[5] Univ Kwazulu Natal, Sch Lab Med, Coll Hlth Sci, Durban, South Africa
来源
FEBS OPEN BIO | 2014年 / 4卷
关键词
Antimycobacterial peptides; ESAT6; Mycobacterium tuberculosis; Protein-protein interaction; ESAT-6-CFP-10; COMPLEX; ESAT-6; PROTEINS; PATHOGENESIS; GROWTH; CFP-10; BIND; BCG;
D O I
10.1016/j.fob.2014.08.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberculosis (TB) is a huge global burden, with new and resistant strains emerging at an alarming rate, necessitating an urgent need for a new class of drug candidates. Here, we report that SL3, a novel 33-amino acid peptide, causes debilitating effects on mycobacterial morphology. Treatment with SL3 drastically inhibits the growth of Mycobacterium tuberculosis in vitro as well as in a pre-clinical mouse model for M.tb infection. Microarray analysis of SL3-expressing strain demonstrates wide-scale transcriptional disruption in M.tb. We therefore believe that SL3 and similar peptides may herald a new approach towards discovering new molecules for TB therapy. (C) 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 50 条
  • [1] A Nonribosomal Peptide Synthase Gene Driving Virulence in Mycobacterium tuberculosis
    Bhatt, Kiranmai
    Machado, Henrique
    Osorio, Nuno S.
    Sousa, Jeremy
    Cardoso, Filipa
    Magalhaes, Carlos
    Chen, Bing
    Chen, Mei
    Kim, John
    Singh, Albel
    Ferreira, Catarina M.
    Castro, Antonio G.
    Torrado, Egidio
    Jacobs, William R., Jr.
    Bhatt, Apoorva
    Saraiva, Margarida
    MSPHERE, 2018, 3 (05):
  • [2] MYCOBACTERIUM TUBERCULOSIS VIRULENCE
    Vishnevskiy, B. I.
    Manicheva, O. A.
    Yablonskiy, P. K.
    INFEKTSIYA I IMMUNITET, 2014, 4 (04): : 319 - 330
  • [3] mosR, a Novel Transcriptional Regulator of Hypoxia and Virulence in Mycobacterium tuberculosis
    Abomoelak, Bassam
    Hoye, Elizabeth A.
    Chi, Jing
    Marcus, Sarah A.
    Laval, Francoise
    Bannantine, John P.
    Ward, Sarah K.
    Daffe, Mamadou
    Di Liu, Hong
    Talaat, Adel M.
    JOURNAL OF BACTERIOLOGY, 2009, 191 (19) : 5941 - 5952
  • [4] VIRULENCE OF MYCOBACTERIUM-TUBERCULOSIS
    GRANGE, JM
    FEMS MICROBIOLOGY LETTERS, 1985, 32 (01) : 55 - 60
  • [5] Virulence factors of Mycobacterium tuberculosis
    Maulen, Nancy P.
    REVISTA MEDICA DE CHILE, 2011, 139 (12) : 1605 - 1610
  • [6] Virulence determinants of Mycobacterium tuberculosis
    Quinn, FD
    Newman, GW
    King, CH
    TUBERCULOSIS, 1996, 215 : 131 - 156
  • [7] Pathogenicity and virulence of Mycobacterium tuberculosis
    Rahlwes, Kathryn C.
    Dias, Beatriz R. S.
    Campos, Priscila C.
    Alvarez-Arguedas, Samuel
    Shiloh, Michael U.
    VIRULENCE, 2023, 14 (01)
  • [8] Mycobacterium microti Interferes with Bovine Tuberculosis Surveillance
    Michelet, Lorraine
    de Cruz, Krystel
    Tambosco, Jennifer
    Henault, Sylvie
    Boschiroli, Maria Laura
    MICROORGANISMS, 2020, 8 (12) : 1 - 7
  • [9] Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis
    Dick, Thomas
    Manjunatha, Ujjini
    Kappes, Barbara
    Gengenbacher, Martin
    MOLECULAR MICROBIOLOGY, 2010, 78 (04) : 980 - 988
  • [10] Characterization and Inhibition of a Novel Diterpene Virulence Factor from Mycobacterium tuberculosis
    Mann, Francis Michelle
    FASEB JOURNAL, 2010, 24